Path B Enhancement of NM Department of Agriculture's Produce Safety Program.

项目摘要 该资助机会旨在加强国家农产品安全计划， 确保新鲜水果和蔬菜的安全生产，并执行 美国食品和药物管理局（FDA）法规“种植、收获、包装和运输标准”的要求。 供人类消费的农产品的持有”（称为农产品安全规则）。而 许多国家本身可能没有足够的资源， 这一赠款机会提供了资源，以实施和维持一个可行的，一致的， 有助于减少食源性疾病和微生物危害的监管计划 建立全国统一的食品安全体系。新墨西哥州农业部 （NMDA）有资格申请本合作协议，路径B。 在这项为期五年的合作协议中，NMDA将与FDA合作， 继续奉行“在监管之前和监管期间进行教育”的口号。NMDA将进一步 发展我们的基础设施和能力，在新墨西哥州运行生产安全计划。 该计划的重点将继续与教育，推广和技术援助的种植者 和监管机构。核查和发展该方案的农场库存将继续， 主要重点，同时增强与FDA共享有意义数据的计划能力 和其他司法管辖区。NMDA还将继续开发和完善监管产品 FDA授权的安全检查、合规和执行计划， FDA的满意度

PROJECT ABSTRACT This Funding Opportunity provides for the enhancement of the State Produce Safety Programs to ensure the safe production of fresh fruits and vegetables and to enforce compliance with the requirements of FDA's Regulation “Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption” (referred to as the Produce Safety Rule). While many states may not have sufficient resources on their own, participation in and funding through this grant opportunity provides the resources to implement and maintain a viable, aligned regulatory program contributing to a reduction of foodborne illnesses, microbiological hazards and a nationally integrated food safety system. The New Mexico Department of Agriculture (NMDA) is eligible to apply for this Cooperative Agreement, Path B. Over the course of this five-year cooperative agreement, the NMDA will work with the FDA continuing with the mantra “educate before and while you regulate”. The NMDA will further develop our infrastructure and capacity to operate a Produce Safety Program in New Mexico. The programs focus will continue with education, outreach and technical assistance for growers and regulators. Verification and development of the programs farm inventory will continue to main focus while enhancing the programs capabilities to share meaningful data with the FDA and other jurisdictions. NMDA will also continue to develop and refine a regulatory Produce Safety Inspection, Compliance and Enforcement Program under FDA authority, to the satisfaction of FDA.